CD28 is a major costimulatory signal receptor for T cells. We have used human naive CD4+ cells from cord blood to analyze the effect of the CD28/67 costimulatory pathway on development of T helper (Th) subsets. We show that CD28 costimulation is critical for development of the Th2 cytokineproducing cells and that in the absence of CD28 costimulation, cells are not primed to produce Th2 cytokines and consequently "default" to the Thl subset, independent of the HELPER (Th) cells play a critical role in immune responses, which depend largely on their production of cytokines. Studies of both murine and human cloned CD4+ cells have shown a dichotomy in Th cytokine production and so Th cells are currently categorized into two major subsets, namely Thl and Th2
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CD28 is a major costimulatory signal receptor for T cells. We have used human naive CD4+ cells from cord blood to analyze the effect of the CD28/67 costimulatory pathway on development of T helper (Th) subsets. We show that CD28 costimulation is critical for development of the Th2 cytokineproducing cells and that in the absence of CD28 costimulation, cells are not primed to produce Th2 cytokines and consequently "default" to the Thl subset, independent of the HELPER (Th) cells play a critical role in immune responses, which depend largely on their production of cytokines. Studies of both murine and human cloned CD4+ cells have shown a dichotomy in Th cytokine production and so Th cells are currently categorized into two major subsets, namely Thl and Th2.1-4 The Thl subset produces interleukin-2 (IL-2), interferon-y (IFN-y), tumor necrosis factor-a (TNF-a), and lymphotoxin (LT), but not IL-4 or IL-5. In contrast, the Th2 subset produces IL-4 and IL-5, but are unable to produce IL-2, IFN-y, TNF-a, or LT. The differences in cytokines produced between Th 1 and Th2 cells leads to markedly different immune responses. T h l cells preferentially activate the cellular arm of the immune response, inducing macrophage activation and delayed type hypersensitivity (DTH), whereas Th2 cells activate the humoral arm of the immune response, providing help for B cells and enhancing IgGl and IgE prod~ction.~ Thl and Th2 cells represent highly polarized forms of Th subsets. In the absence of an appropriate polarizing signal a third subset, designated Tho, predominate^.'.^ Tho cells have an unrestricted cytokine profile, producing both Thl and Th2 cytokines and thus can activate both the cellular and humoral arms of the immune response, depending on the ratio of Thl to Th2 cytokine production. The original studies carried out by Mosmann et all used antigen-specific clones derived from inbred mouse strains to classify Th subsets. Since this original description of Th subsets, further studies have been unable to identify such clear cut Th subsets and as a consequence Th cells are often described as either Thl-like or Th2-like depending on the ratio of Thl to Th2 cytokines produced.
Differentiation into Th subsets occurs early after exposure to antigen (Ag). Studies in the mouse show that the development of naive CD4' cells into either subset depends on the presence of different cytokines at the site of primary Ag stimulation, the effective concentration of Ag and the nature of the antigen presenting cell (APC). The cytokines IFN-a, IFN-y, and IL-12 can promote differentiation of murine naive Th cells into the Thl subset, whereas IL-4 is the only cytokine known to promote differentiation of cells to the Th2 subset.8"' In addition, there is an unknown effect of genetic background on Th subset development. Inbred strains of mice generate either a Thl or Th2 response to parasites depending on their genetic background. This is best illustrated by experimental infection with Leishmania major where a Thl response is mounted by C57BL/6 and C3H/HeN mice, which renders them resistant to infection; in contrast, presence of exogenous cytokines. After CD28 costimulation. cells differentiate into a subset that produces Th2 cytokines. However, further CD28 costimulation is not required to maintain Th2 cytokine production. We conclude that CD28 costimulation is critical for the development of Tho and Th2 subsets, but not for the maintenance of cytokine production. Q 1995 by The American Society of Hematology.
BALB/c mice mount a Th2 response and die after infection.I2-l4 Receptor-counter receptor interactions may also play a role in the development of Th subsets. The CD28B7 costimulatory pathway enhances secretion of several lymphokines including IL-2, IFN-y, TNF-a, LT, and granulocyte-macrophage colony-stimulating factor (GM-CSF),'* and also the in vitro development of both murine Thl and Th2 subsets." In vivo studies show that blocking CD28-dependent signaling with a soluble form of CTLA-4 inhibits Th2 cell-dependent antibody production," and also abrogates progressive disease in Leishmaniasis-susceptible BALB/c mice by decreasing levels of biologically active IL-4 and increasing levels of IFN-y." In addition, transgenic mice expressing a soluble form of CTLA-4 have reduced IL-4 production in response to primary immunizationL9 and CD28-deficient mice have reduced ThZmediated antibody responses to vesicular stomatitis virus (VSV), without defects in Thl regulated DTH reactions following infection with lymphocytic choriomeningitis virus (LCMV).20 These studies suggest a role of CD28 costimulation in the generation of Th2 cells.
The studies described above have used murine models of Th subset development. Human studies have shown that either IL-12 or IFN-a can prime human naive cells toward the Thl however, human Th2 subset development has remained enigmatic. We have investigated the role of CD28 costimulation in the differentiation of human naive CD4' cells isolated from cord blood into the Thl and Th2 subsets. Our data show that CD28 costimulation enhances both naive T-cell proliferation and subsequent cytokine production. More interestingly, we show that costimulation is a critical requirement for the development of Th2, but not 3480 WEBB AND FELDMANN Th 1, cytokine-producing cells. In addition, once cells have differentiated into the Th2 cytokine-producing cells, further CD28 costimulation is not required for the maintenance of Th2 cytokine production.
MATERIALS AND METHODS
Reagents. T-cell activation was performed using OKT3, a monoclonal antibody (MoAb) directed against CD3 (American Type Culture Collection, Maryland) and 9. Cell purijication and assessment. Blood was collected from the cut umbilical cord into preheparinized containers following agreement with The Riverside Research Ethics Committee, Charing Cross Hospital, London, UK. Cord blood mononuclear cells were isolated by density centrifugation over Ficoll-Hypaque Lymphoprep (Nycomed, Oslo, Norway). Interface cells were washed three times in 2% FCS, HBSS without calcium or magnesium (GIBCO) and CD4+ cells isolated by positive selection with anti-CD4 MoAb coated Dynabeads (Dynal, AS., Oslo, Norway) by a 60-minute incubation at 4°C. Cells were washed three times to remove unbound cells and immunomagnetic beads were removed from cells by incubation with Detachabead (an anti-Fab antibody; Dynal) at room temperature for 1 hour. Detached cells were then removed from beads using the immunomagnetic particle concentrator (Dynal) and washed three times. Cell purity was assessed by incubation with FITC-or PE-conjugated MoAbs to various cell surface markers according to manufacturers' instructions. Cells were fixed in 3% paraformaldehyde-PBS until evaluation by Flow cytometry (Becton Dickinson). Umbilical cord blood CD4' cells isolated by immunomagnetic purification were greater than 99% CD4', 95% to 99% CD4SRA'CD4SRO-.
Cell culture and stimulation. For primary culture, 96-well, flatbottomed tissue culture plates (Falcon; Marathon Laboratory Supplies, London, UK) were coated with 100 pL of 10 pg/mL solution of OKT3 in RPMI-I640 (GIBCO) for at least 3 hours at 37°C; wells were washed three times with RPMI before a 30-minute incubation with 10% human serum RPMI. Wells were washed a further two times before addition of cells at a final concentration of 1 X IOh/ mL in 10% human serum, RPMI, 200 pL/well. Soluble anti-CD28 was used as a costimulus at 10 n g / d final concentration. IL-2, IL-4, or IL-12 were also added into culture at a final concentration of I O ng/mL. After 3 days, cells were expanded into 24-well plates (Falcon) and IL-2, IL-4, or IL-l2 were added into cultures at 10 ng/ mL final concentrations in a final volume of 1 mL. After 4 days of expansion, cells were washed three times in 2% FCS, RPMI, incubated for 2 hours at room temperature to remove exogenous cytokine, and restimulated at a concentration of IO"/mL in 1 0 % human serum, RPMI for 24 hours with 10 ng/mL PMA and 1 pg/mL ionomycin. Supernatants were collected and placed on enzyme linked irnmunosorbant assays (ELISA) or bioassays. For secondary culture, cells were placed onto 96-well plates coated with OKT3 and cultured as described above. For proliferation assays, IO" cells/mL were cultured in OKT3-coated 96-well plates as described above in a final volume of IO0 pL with either IL-2 (10 ng/mL) and/or anti-CD28 MoAb ( I O ng/mL) in 10% human serum RPMI for S days.
Detection ofcytokines. IL-4, IFN-7, and IL-5 levels in supernatants were determined by specific capture ELlSA with sensitivities of 40 pg/mL, 120 pg/mL, and SO pg/mL, reagents donated by Drs F. di Padova (Sandoz, Basel, Switerzland), D. Novick (Weizmann Institute, Rehovot, Israel), and J. Abrams (DNAX, Palo Alto, CA), respectively. IL-2 levels were determined using a standard CTLL bioassay with a sensitivity of 20 pg/mL. Samples were assayed in duplicate for ELISA and in triplicate for the CTLL bioassay and quantitated by comparison with standard curves of purified recombinant cytokine (variation in ELISA duplicates and bioassay triplicates <5%).
Thymidine incorporation. DNA synthesis was assessed on day 5 of culture, by adding O S pCi/well ['HI-thymidine (Amersham, Buckingham, UK) before harvesting 8 hours later onto glass fiber filters (Pharmacia LKB, Biotechnology, Uppsala, Sweden) and radioactivity was counted by liquid scintillation. ['HI-thymidine incorporation was expressed as counts per minute 2 standard deviation of triplicate cultures.
RESULTS

Costimulation via CD28 enhances proliferation o j human naive CD4' cells to anti-CD3 and IL-2.
To analyze the effect of CD28 costimulation on human naive CD4' cells, we used an APC-free system to eliminate costimulation by accessory molecules present on APCs. Naive CD4' cells were purified from cord blood mononuclear cells (CBMCs) yielding a pure (>99%) population of unactivated cells as described in experimental procedures. Purified CD4' cells were stimulated by crosslinking the T-cell receptor (TCR)/ CD3 complex using plastic-immobilized anti-CD3 MoAb. To stimulate cells via the CD28 molecule, soluble anti-CD28 MoAb was added to cultures. A predetermined optimal dose of IL-2 andor anti-CD28 was added to cells and proliferation was assessed on day 5 by measuring ['Hlthymidine incorporation (counts per minute; cpm) during the final 8 hours of culture. As shown in Fig 1, proliferation did not occur in the absence of CD3 stimulation and both IL-2 and anti-CD28 enhanced anti-CD3-induced proliferation. A marked increase in cell proliferation was consistently observed when cells were costimulated via CD3 and CD28 in the presence of IL-2 (Fig 1) . An IgG2a isotype control had no effect on anti-CD3 and IL-2-induced proliferation of naive CD4' cells (data not shown).
CD28 costimulation enhances cytokine production by human CD4+ cells. It has been shown that human naive CD4' cells are unable to express certain lymphokine genes on primary in vitro stimulation but can be induced to undergo functional in vitro differentiation by stimulation via CD3 and growth in exogenous IL-2 for a period of 7 to 10 days. duction by human CD4' cells. Naive CD4' cells were purified from neonatal blood as described above and stimulated via CD3 in the presence or absence of anti-CD28; exogenous IL-2 was added on day I, and on day 3 cells were expanded in fresh medium plus IL-2. On day 7, cells were washed 3 times and restimulated for 24 hours using a combination of PMA and ionomycin. Supernatants were taken at 24 hours post stimulation .and then assayed for IL-2, IFN-y, IL-4, and IL-S. Cells stimulated via CD3 alone were able to produce IFN-y and IL-2, but were unable to produce the Th2 cytokines IL-4 and IL-S (Fig 2, A through D) . Costimulation via CD28 enhanced Thl cytokine production (Fig 2, A and B) but more interestingly yielded a population of cells that could produce significant levels of the Th2 cytokines, IL-4, and IL-5 (Fig 2, C and D) . We repeatedly found that CD28 costimulation yielded a population of cells able to produce both Th 1 and Th2 cytokines and that in the absence of CD28 costimulation cells would "default" to a phenotype only able to produce Thl cytokines.
IL-l2 and IL-4 alterhuman Th subset development. Studies using murine naive CD4' cells have shown that 1L-12 and IL-4 prime cells to produce Thl and Th2 cytokines. respe~tively."".'~.~~ We analyzed the effect of CD28 costimulation on IL-12 or IL-4-induced development of human Th I and Th2 cells by culturing naive cells as described above in the presence or absence of a predetermined optimal dose of exogenous IL-12 or IL-4. As shown in Fig 3A, the presence of IL-12 enhanced production of the Thl cytokine, IFN-y, in the absence of CD28 costimulation. However, inclusion of anti-CD28 MoAb enhanced this IL-12-induced IFN-y production by threefold to fourfold. In contrast, coculture with IL-4 had only a slight inhibitory effect on IFNy production even in the presence of anti-CD28.
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IL-12 had no significant effect on development of Th2 cells because it altered neither IL-4 nor IL-S production ( Fig  3, C and D) , irrespective of the presence of anti-CD28. In contrast, while inclusion of IL-4 alone had no effect on Th2 cytokine production (Fig 3, C and D) the combination of IL-4 and anti-CD28 lead to high levels of both IL-4 and 1L-S production. IL-4 was able to enhance the production of Th2 cytokines only when cells were primed using anti-CD28 MoAb as a costimulus. In the absence of anti-CD28 MoAb. naive cells failed to develop into Th2 cytokine-producing cells, even in the presence of exogenous IL-4. Exogenous IL-I2 had no effect on development of Th2 cytokine producing cells. CD28 costimulation was essential for the development of Th2 cytokine-producing cells and was enhanced by exogenous IL-4.
Development of ThZ cytokine-producing cells is dependent on CD28 costimulation. To confirm that CD28 costimulation is a requirement for development of Th2 cytokine-producing cells, naive CD4' cells were stimulated via CD3 in the presence of IL-2 and IL-4 along with different concentrations of anti-CD28. As shown in Fig 4, the development of mL of anti-CD28 is an optimal concentration to use for these studies. Memory Th cells produce Th2 cytokines independent of CD28 costimulation. The above work clearly shows a requirement for CD28 costimulation in the development of human Th2 cytokine-producing cells. However, previous studies have shown that IL-4 secretion by in vitro differentiated murine Th2 cells is not dependent on such costimulation," implying that the initial requirement for costimulation is transient. Hence, we sought to determine if CD28 costimulation is required for the maintenance of Th2 cytokine production by human cells already primed to this phenotype. After their initial 7-day priming (during which cells were co-stimulated via CD3 and CD28 grown in IL-2, IL-2 plus IL-4, or IL-2 plus IL-12), cells were restimulated via CD3 in the presence or absence of anti-CD28 MoAb and again grown in !L-2, IL-2 and IL-4, or IL-2 and IL-12 for a further 7 days. After this secondary culture, cells were then washed and restimulated for 24 hours to determine their resultant cytokine profile. As shown in Fig 5, CD28 costimulation was not required for production of the Th2 cytokines IL-4 and IL-5 by cells that had been previously costimulated. Furthermore, CD28 costimulation of memory cells did not enhance their production of Th2 cytokines. Thus, once cells have been primed to a Th2 cytokine-producing phenotype by CD28 costimulation, further costimulation is not required to maintain production of Th2 cytokines.
CD2Rinducecl Ti12 cytokine production is not due to enhanced production of IL-2. CD28 costimulation can significantly enhance IL-2 production. Because IL-2 is also critical for IL-4 production by Th cells," we sought to determine if CD28 costimulation induced development of Th2 cells via its ability to enhance IL-2 production. We analyzed the effect of a supra-optimal concentration of exogenous IL-2 on development of Th2 cells. Cells were cultured for 7 days in the presence or absence of anti-CD28 and/or IL-4 with two different concentrations of IL-2: an optimal dose (IO ng/mL) or a supra-optimal dose ( 1 0 0 ng/mL). IL-4-production by primed cells was assessed following restimulation for 24 hours with PMA and ionomycin. The increased dose of exogenous IL-2 did not induce development of IL-4-producing cells, independently of exogenous IL-4. Development of Th2 cytokineproducing cells was only seen when cells were costimulated via CD28. IL-4-producing cells developed in the absence of exogenous IL-4. The presence of IL-4 during priming enhanced subsequent production of Th2 cytokines. The increased concentration of exogenous IL-2 slightly enhanced production of IL-4 but only when cells had been costimulated via CD28 (Fig 6) . in the absence of CD28 costimulation Th2 cytokine-producing cells did not develop and this was independent of the concentration of exogenous IL-2 added.
DISCUSSION
The role of CD28 costimulation in T-cell activation has been of considerable interest. In vitro studies have shown 3483 that CD28 costimulation can augment mitogen and anti-CD3-induced T-cell proliferation," amplify the production of multiple T-cell cytokines,ls and prevent induction of anergy in T-cell clones.'x.3' CD28 costimulation can also induce responsiveness to IL-4 in both Thl" and Th233 cell clones. However, the role of CD28 costimulation during the early stages of human Th subset development has, until now, remained enigmatic.
To analyze the role of CD28 costimulation in the development of Th subsets it is essential that the starting population is antigenically naive. Approximately, 40% of CD4' cells in adult blood were thought to be naive due to their expression of the CD45RA isoform and lack of the CD4SRO isoform expression. However, studies have shown that a memory cell, expressing CD45R0, can revert back to CD4SRA expression from CD4SRA to CD4SRO expression is cyclical. Thus, expression of the CD45RA isoform in adult blood does not represent a naive population of cells and such cells would not be appropriate for this study. Hence, by using neonatal blood taken from umbilical cords our source of naive CD4' cells are taken early in the development of the immune system. Neonatal T cells are naive with respect to antigenic stimulation, cytokine production (producing only IL-2). and also cell surface marker expression (CD45RA'CD45RO-CD3 I +).'l In order to elirni- CD28-induced Th2 cytokine production does not occur by enhancing exogenous 11-2. Naive CD4' cells were cultured as described in the legend t o Fig 3 with anti-CD3 or anti-CD3 plus anti-CD28 and grown in IL-2 or 11-2 plus IL4. The effect of optimal or supraoptimal concentration of IL-2 on development of IL-4-producing cells was assessed by using exogenous 11-2 at either 10 ng/mL or 100 ng/ mL. IL-4 production was measured after a 24-hour restimulation with PMA plus ionomycin. (B) Cytokine production after costimulation via CD3 and CD28 and growth in an optimal concentration of 11-2 (10 nglmLI. (m) Cytokine production after costimulation via CD3 and CD28 and growth in a supra-optimal concentration of IL-2 (100 ng/ mL). No IL-4 production was detected after priming in the absence of anti-CD28. Results are representative of three separate experiments using blood from different donors. The sensitivity of the IL-4 ELISA was 40 pglmL.
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From nate costimulation by other accessory molecules, we used an MC-free culture (as assessed by flow cytometry and the lack of proliferation of cells to soluble anti-CD3). CD4+ cells were purified from CBMCs and then stimulated with plate-immobilized anti-CD3, and grown in IL-2. An optimal concentration of IL-2 was used throughout culture to ensure that any effect of co-stimulation via CD28 was not merely due to CD28-enhanced production of IL-2. To mimic the stimulatory interaction between B7 molecules and CD28, an agonistic MoAb to CD28 was added into the initial culture. For detection of cytokines, we chose to measure secreted cytokines as opposed to cytokine message, since the detection of cytokine mRNA does not confirm cytokine secretion and may be of little physiological significance.
This study of human Th subset development draws a number of parallels with development of Th subsets in the mouse. Previous murine studies have shown that IL-12 and IL-4 are the main factors that induce development of the Thl and Th2 subsets, respectively.x~' '2425 Our data confirm this observation in human cells.
However, by using an APC-free system, we have been able to further define the activation requirements for subset development. Murine studies have invariably used culture systems where APCs are present. APCs will express ligands for CD28 and other T-cell surface molecules (eg, ICAMl , CD40L, CD44, etc). In one murine study, blocking the interaction of CD28 with its ligands by adding CTLA-41g showed that CD28 costimulation was critical for the development of both Thl and Th2 subsets from naive cells.'' However, this requirement for CD28 costimulation could be overcome by addition of exogenous IL-2. In contrast, we find that human naive cells require IL-2 for development of both Th 1 and Th2 cytokine-producing cells, independent of CD28 costimulation (data not shown), but human Th2 subset development shows an absolute requirement for CD28 costimulation, which cannot be overcome by excess exogenous IL-2. An increase in the concentration of exogenous IL-2 did not allow development of Th2 cells in the absence of CD28 costimulation. Thus, although CD28 induction of IL-2 production is critical for Th2 cytokine production, clearly other CD28-stimulated events are also important. CD28 costimulation not only allowed development of a Th2-like subset but also enhanced anti-CD3-induced proliferation of naive CD4+ cells and secretion of the Thl cytokines IL-2 and IFN-y. Thus, it could be argued that the production of Th2 cytokines seen after CD28 costimulation was merely due to an enhancement in production of all T-cell cytokines. However, even if Th2 cytokines were being secreted at levels just below the detection limits of the ELISA then CD28 costimulation enhanced Th2 cytokine production by at least 40-to 100-fold but only enhanced Thl cytokine production CD28 has been reported to enhance transcription" and stabilization of cytokine mRNAs." Hence, it is possible that CD28 costimulation may enhance transcription and stabilization of IL-4 mRNA, inducing autocrine production of IL-4 during initial stimulation, which could allow development of the Th2 subset. However, in our system, addition of 1L-by 3-to 5-fold.
4 during priming could not induce Th2 subset development in the absence of CD28 costimulation (even when the concentrations of exogenous IL-4 exceeded 100 ng/mL; data not shown). In addition, we also find that CD28 costimulation does not induce production of 1L-4 during priming (data not shown). Thus, mechanisms involving enhanced transcription and stabilization of IL-4 message by CD28 costimulation during priming, though probably important, are not critical for Th2 subset development. Thus, the mechanism by which CD28 costimulation induces Th2 subset development remains elusive. Our finding that Th2 cytokine production by memory cells occurs in the absence of costimulation agrees with a previous study in mice in which IL-4 secretion occurred independently of CD28 costimulation after naive cells had been first primed with APCs and Ag.'" In our study, IL-4 induction of Th2 subset development showed an absolute requirement for the presence of anti-CD28, but once naive cells have acquired the ability to produce Th2 cytokines. we found that subsequent Th2 cytokine production occurred independently of CD28 costimulation, suggesting that memory and naive cells differ in their costimulatory requirements. We have been able to maintain the phenotype of Th2 cytokine production for several weeks by immobilized anti-CD3 stimulation and growth in IL-2 (data not shown).
There are currently two CD28 ligands, namely B7-1 (CD80) and B7-2 (CD86). The existence of a further CD28 ligand, B7-3, has been postulated'* but not yet proven by molecular cloning. Numerous studies have analyzed the expression of CD80 and CD86 and have shown that these two ligands are regulated differently; CD86 expression tends to precede that of CD80 during the development of the immune response." The existence of CD28 ligands and their different patterns of expression imply that these ligands serve distinct functions. Hence, studies are currently underway to analyze the effect of CD28 engagement by CD80 and CD86 on human Th subset development.
In vitro models of human Th subset development have shown that 1L-12 induces development of a ThI-like subset." We also found that addition of IL-12 enhanced Thl cytokine production, while addition of IL-4 inhibited Thl cytokine production, irrespective of costimulation. CD28 costimulation synergized with L 1 2 to enhance Thl cytokine production. In agreement with our study, there have been two reports that stimulation via CD3 and growth in IL-2 and IL-4 is insufficient to prime human naive CD4' cells to a subset able to produce Th2 cytokine~.~".'' In the first study, inclusion of a CD32 transfected mouse fibroblast cell line allowed development of Th2 cells and since the use of this fibroblast line was of critical importance for production of Th2 cytokines, it was postulated that they were providing an accessory signal.'" It is possible that ligands for CD28, present on the transfected cell line, were allowing costimulation via CD28. In agreement with our study, Kalinski et al'" have also found that CD28 costimulation allows development of human naive CD4 ' cells to a phenotype capable of secreting IL-4. In addition, they observed that there was no IL-4 production during the priming period. The model SYSFor personal use only. on November 16, 2017 . by guest www.bloodjournal.org From DEVELOPMENT OF Th2 CYTOKINE-PRODUCING CELLS 3485 tem used by Kalinski et a1 differed from ours in their source of naive cells; they used naive CD4+ cells purified from adult peripheral blood on the basis of CD45 isoform expression.4' Although this study clearly showed a role for CD28 costimulation in the development of adult naive CD4' cells into Th2 cytokine-producing cells, given the controversy regarding the use of CD45 isoforms as markers of the naivety of the cells used in their study is debatable.
Recently, in vivo blockade of the CD28-B7 pathway has shown differential effects on Thl and Th2 effector subset development in experimental Leishmaniasis. Susceptible mice generate Th2 effector cells in response to Leishmania major; however, administration of CTLA-41g during the first week of infection abrogates this progressive disease in susceptible mice, but has no effect on the protective immune response developed by the resistant mice, which generate T h l effector cells." This implied that CTLA4Ig prevented development of Th2 cells without effecting development of Thl cells. More curiously, continuous administration of CTLA-41g abolished the capacity of the resistant mice to contain infection, implying that maintenance of Thl cytokine production is dependent on CD28 costimulation. This has been elegantly demonstrated in in vitro activation of murine Th subsets26 and also studies using human Thl clones42 or primed human CD4+ T cells taken from adult blood!3 Taken together these data point to a reciprocal role for CD28 costimulation in the generation and maintenance of Th subsets. Thl subsets develop independently of CD28 costimulation but subsequently require costimulation for survival. In contrast, Th2 cells require CD28 costimulation for their initial development but then remain CD28 independent. Thus, the ligands for CD28 can differentially regulate T h l and Th2 cytokine production depending on the differentiation state of the T cell.
